A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.
Clinical trial NCT06823752 · RECRUITING
Trial details
- NCT number
- NCT06823752
- Sponsor
- Woolcock Institute of Medical Research
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2026-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.